Overview of Phase 3 Perfluorohexyloctane Studies at AAO 2023
Richard Adler, MD, FACS, discusses corneal fluorescein staining data presented at AAO 2023 from the pooled analysis of 2 phase 3 studies.
Source: ajmc.com
Stay updated with breaking news from Corneal Staining. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Richard Adler, MD, FACS, discusses corneal fluorescein staining data presented at AAO 2023 from the pooled analysis of 2 phase 3 studies.
Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye disease (DED).